Javascript must be enabled to continue!
Cell-Free Versus Cell-Seeded Tissue-Engineered Heart Valves: Lessons From Preclinical and Clinical Studies
View through CrossRef
Tissue-engineered heart valves (TEHVs) have been developed to overcome the limitations of current prosthetic valves, which lack growth, repair, and remodeling capacity. While early TEHV strategies relied on pre-seeded cells, recent approaches have shifted toward cell-free scaffolds designed to promote in situ tissue regeneration; however, the relative advantages and limitations of these strategies remain unclear. This review synthesizes evidence from preclinical and clinical studies of TEHVs, including fully synthetic biodegradable scaffolds, decellularized xenografts, decellularized allografts, engineered decellularized matrices, and cell-seeded constructs, with a focus on scaffold composition, recellularization, extracellular matrix (ECM) formation, and functional durability. Overall, cell-free TEHVs demonstrate the ability to recruit host cells and support tissue formation, but remodeling is frequently incomplete and heterogeneous, particularly in valve leaflets. Decellularized xenografts show limited durability due to persistent immunogenicity, whereas decellularized allografts provide the most consistent clinical performance but exhibit incomplete recellularization and variable long-term outcomes. Fully synthetic and engineered decellularized scaffolds enable in situ regeneration but are often associated with geometric instability and maladaptive remodeling. Cell-seeded TEHVs can enhance early endothelialization and matrix deposition; however, challenges remain in cell retention, survival, and regulation of remodeling, with no consistent long-term superiority. Taken together, neither purely cell-free nor cell-seeded strategies alone reliably achieve durable valve regeneration, and the primary challenge lies in controlling remodeling rather than the presence of seeded cells, supporting the development of integrated approaches that combine scaffold design with biological modulation to improve long-term valve function.
Title: Cell-Free Versus Cell-Seeded Tissue-Engineered Heart Valves: Lessons From Preclinical and Clinical Studies
Description:
Tissue-engineered heart valves (TEHVs) have been developed to overcome the limitations of current prosthetic valves, which lack growth, repair, and remodeling capacity.
While early TEHV strategies relied on pre-seeded cells, recent approaches have shifted toward cell-free scaffolds designed to promote in situ tissue regeneration; however, the relative advantages and limitations of these strategies remain unclear.
This review synthesizes evidence from preclinical and clinical studies of TEHVs, including fully synthetic biodegradable scaffolds, decellularized xenografts, decellularized allografts, engineered decellularized matrices, and cell-seeded constructs, with a focus on scaffold composition, recellularization, extracellular matrix (ECM) formation, and functional durability.
Overall, cell-free TEHVs demonstrate the ability to recruit host cells and support tissue formation, but remodeling is frequently incomplete and heterogeneous, particularly in valve leaflets.
Decellularized xenografts show limited durability due to persistent immunogenicity, whereas decellularized allografts provide the most consistent clinical performance but exhibit incomplete recellularization and variable long-term outcomes.
Fully synthetic and engineered decellularized scaffolds enable in situ regeneration but are often associated with geometric instability and maladaptive remodeling.
Cell-seeded TEHVs can enhance early endothelialization and matrix deposition; however, challenges remain in cell retention, survival, and regulation of remodeling, with no consistent long-term superiority.
Taken together, neither purely cell-free nor cell-seeded strategies alone reliably achieve durable valve regeneration, and the primary challenge lies in controlling remodeling rather than the presence of seeded cells, supporting the development of integrated approaches that combine scaffold design with biological modulation to improve long-term valve function.
Related Results
Complex Collision Tumors: A Systematic Review
Complex Collision Tumors: A Systematic Review
Abstract
Introduction: A collision tumor consists of two distinct neoplastic components located within the same organ, separated by stromal tissue, without histological intermixing...
Pembrolizumab and Sarcoma: A meta-analysis
Pembrolizumab and Sarcoma: A meta-analysis
Abstract
Introduction: Pembrolizumab is a monoclonal antibody that promotes antitumor immunity. This study presents a systematic review and meta-analysis of the efficacy and safety...
Early In Vivo Experience With Tissue-Engineered Trileaflet Heart Valves
Early In Vivo Experience With Tissue-Engineered Trileaflet Heart Valves
Background
—Tissue engineering is a new approach in which techniques are being developed to transplant autologous cells onto biodegradable scaffolds to ultimately form ...
Study of the collection sesame samples in the Rostov region
Study of the collection sesame samples in the Rostov region
From 2018 to 2020, there was studied a collection of sesame varieties of various ecological and geographical origin at the Don Experimental Station, a branch of the Federal State B...
Opening up "containment": Technological and social dimensions of biocontainment for genetically engineered organisms designed for deliberate release
Opening up "containment": Technological and social dimensions of biocontainment for genetically engineered organisms designed for deliberate release
Advances in engineering biology, together with growing interest and investment in supporting a bio-based economy in the US, are fueling research and development efforts into geneti...
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Abstract
Introduction
Tarlatamab is a Delta-like ligand 3 (DLL3) -directed bispecific T-cell engager recently approved for use in patients with advanced small cell lung cancer (SCL...
new insights into the pathophysiology of rheumatic valve disease based on different genetic and proteomics profiles
new insights into the pathophysiology of rheumatic valve disease based on different genetic and proteomics profiles
Abstract
Introduction
Rheumatic heart disease (RHD) pathogenesis is not fully understood. Purpose The protein profile in rheumat...

